Cargando…

Genomics and Therapeutic Vulnerabilities of Primary Bone Tumors

Osteosarcoma, Ewing sarcoma and chondrosarcoma are rare diseases but the most common primary tumors of bone. The genes directly involved in the sarcomagenesis, tumor progression and treatment responsiveness are not completely defined for these tumors, and the powerful discovery of genetic analysis i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Scotlandi, Katia, Hattinger, Claudia Maria, Pellegrini, Evelin, Gambarotti, Marco, Serra, Massimo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227002/ https://www.ncbi.nlm.nih.gov/pubmed/32295254 http://dx.doi.org/10.3390/cells9040968

Ejemplares similares

Strategies to Overcome Resistance to Immune-Based Therapies in Osteosarcoma
por: Hattinger, Claudia Maria, et al.
Publicado: (2023)

Pharmacogenomic Profiling of Cisplatin-Resistant and -Sensitive Human Osteosarcoma Cell Lines by Multimodal Targeted Next Generation Sequencing
por: Hattinger, Claudia Maria, et al.
Publicado: (2022)

Targeting Glutathione-S Transferase Enzymes in Musculoskeletal Sarcomas: A Promising Therapeutic Strategy
por: Pasello, Michela, et al.
Publicado: (2011)

Drug Resistance in Osteosarcoma: Emerging Biomarkers, Therapeutic Targets and Treatment Strategies
por: Hattinger, Claudia Maria, et al.
Publicado: (2021)

Pharmacogenomics and Pharmacogenetics in Osteosarcoma: Translational Studies and Clinical Impact
por: Hattinger, Claudia Maria, et al.
Publicado: (2020)

Clinical, Histological, and Molecular Features of Solitary Fibrous Tumor of Bone: A Single Institution Retrospective Review
por: Bianchi, Giuseppe, et al.
Publicado: (2021)

Unraveling the IGF System Interactome in Sarcomas Exploits Novel Therapeutic Options
por: Mancarella, Caterina, et al.
Publicado: (2021)

CD99: A Cell Surface Protein with an Oncojanus Role in Tumors
por: Manara, Maria Cristina, et al.
Publicado: (2018)

CD99 polymorphisms significantly influence the probability to develop Ewing sarcoma in earlier age and patient disease progression
por: Martinelli, Marcella, et al.
Publicado: (2016)

Impact of ABC Transporters in Osteosarcoma and Ewing’s Sarcoma: Which Are Involved in Chemoresistance and Which Are Not?
por: Serra, Massimo, et al.
Publicado: (2021)

Candidate germline polymorphisms of genes belonging to the pathways of four drugs used in osteosarcoma standard chemotherapy associated with risk, survival and toxicity in non-metastatic high-grade osteosarcoma
por: Hattinger, Claudia M., et al.
Publicado: (2016)

Patient Derived Xenografts for Genome-Driven Therapy of Osteosarcoma
por: Landuzzi, Lorena, et al.
Publicado: (2021)

ROCK2 deprivation leads to the inhibition of tumor growth and metastatic potential in osteosarcoma cells through the modulation of YAP activity
por: Zucchini, Cinzia, et al.
Publicado: (2019)

Genome maintenance in retinoblastoma: Implications for therapeutic vulnerabilities
por: Lee, Chunsik, et al.
Publicado: (2022)

Cisplatin Resistance in Osteosarcoma: In vitro Validation of Candidate DNA Repair-Related Therapeutic Targets and Drugs for Tailored Treatments
por: Fanelli, Marilù, et al.
Publicado: (2020)

A 3D Collagen-Based Bioprinted Model to Study Osteosarcoma Invasiveness and Drug Response
por: Pellegrini, Evelin, et al.
Publicado: (2022)

Therapeutic vulnerability to PARP1,2 inhibition in RB1-mutant osteosarcoma
por: Zoumpoulidou, Georgia, et al.
Publicado: (2021)

CCN proteins in the musculoskeletal system: current understanding and challenges in physiology and pathology
por: Giusti, Veronica, et al.
Publicado: (2021)

CD99 at the crossroads of physiology and pathology
por: Pasello, Michela, et al.
Publicado: (2018)

Reprogramming Tumor-Immune Cell Interface in Solid and Hematological Malignancies to Enhance Response to Therapy
por: Di Martino, Maria Teresa, et al.
Publicado: (2018)

Combined use of expression and CGH arrays pinpoints novel candidate genes in Ewing sarcoma family of tumors
por: Savola, Suvi, et al.
Publicado: (2009)

Novel Regulators of the IGF System in Cancer
por: Mancarella, Caterina, et al.
Publicado: (2021)

PROTAC-Based Protein Degradation as a Promising Strategy for Targeted Therapy in Sarcomas
por: Mancarella, Caterina, et al.
Publicado: (2023)

Primary malignant ossifying fibromyxoid tumour of the bone. A clinicopathologic and molecular report of two cases
por: Sbaraglia, Marta, et al.
Publicado: (2020)

Targeting CDKs with Roscovitine Increases Sensitivity to DNA Damaging Drugs of Human Osteosarcoma Cells
por: Vella, Serena, et al.
Publicado: (2016)

Vaginal metastasis of a Ewing sarcoma five years after resection of the primary tumor
por: Vanel, Noemie, et al.
Publicado: (2011)

Solitary bone lesions: which ones to worry about?
por: Vanel, Daniel, et al.
Publicado: (2012)

Novel Targeting of DNA Methyltransferase Activity Inhibits Ewing Sarcoma Cell Proliferation and Enhances Tumor Cell Sensitivity to DNA Damaging Drugs by Activating the DNA Damage Response
por: Cristalli, Camilla, et al.
Publicado: (2022)

miR-214-3p Is Commonly Downregulated by EWS-FLI1 and by CD99 and Its Restoration Limits Ewing Sarcoma Aggressiveness
por: De Feo, Alessandra, et al.
Publicado: (2022)

CIC-Rearranged Sarcomas: An Intriguing Entity That May Lead the Way to the Comprehension of More Common Cancers
por: Mancarella, Caterina, et al.
Publicado: (2022)

Sea turtle fibropapilloma tumors share genomic drivers and therapeutic vulnerabilities with human cancers
por: Duffy, David J., et al.
Publicado: (2018)

Giant Cell Tumor of Bone in Patients under 16 Years Old: A Single-Institution Case Series
por: Ambrosi, Francesca, et al.
Publicado: (2021)

Therapeutic Targeting of Tumor Cells and Tumor Immune Microenvironment Vulnerabilities
por: Kalyanaraman, Balaraman, et al.
Publicado: (2022)

Synovial Sarcoma Preclinical Modeling: Integrating Transgenic Mouse Models and Patient-Derived Models for Translational Research
por: Landuzzi, Lorena, et al.
Publicado: (2023)

Innovative Breakthroughs for the Treatment of Advanced and Metastatic Synovial Sarcoma
por: Landuzzi, Lorena, et al.
Publicado: (2023)

Glutamatergic Signaling a Therapeutic Vulnerability in Melanoma
por: Eddy, Kevinn, et al.
Publicado: (2021)

High-resolution structural genomics reveals new therapeutic vulnerabilities in glioblastoma
por: Johnston, Michael J., et al.
Publicado: (2019)

IGF2BP3 From Physiology to Cancer: Novel Discoveries, Unsolved Issues, and Future Perspectives
por: Mancarella, Caterina, et al.
Publicado: (2020)

MiRNAs in Canine and Human Osteosarcoma: A Highlight Review on Comparative Biomolecular Aspects
por: Leonardi, Leonardo, et al.
Publicado: (2021)

KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors
por: Terribas, Ernest, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_chg9puh9mgmp87p4dpnsluma09